Listar Ciencias de la Salud por tema "Tumour necrosis factor alpha"
Mostrando ítems 1-1 de 1
-
Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis
(2021) [Artículo de periódico]Objectives To assess efficacy, pharmacokinetics (PK) and safety of intravenous (i.v.) golimumab in patients with polyarticular-course JIA (pc-JIA). Methods Children aged 2 to <18 years with active pc-JIA despite MTX therapy ...